Swissmedic authorised the immunisation of children aged five to eleven years old with Pfizer-Comirnaty Biontech’s vaccine on Friday.
“Clinical trial results show that the vaccine is safe and effective in this age group,” it said in a statement.
Health: Global Capability Centres Grapple with Unhealthy Gender Ratio Global Capability Centres (GCCs) have emerged…
Autism: The Leading Health Concern Among Global Youth Autism Spectrum Disorder (ASD) is increasingly being…
Chinese Garlic: Did you know that Chinese garlic has been banned in India? This garlic…
Wake Up in Winter: Waking up in the winter mornings can be tough, especially when…
Alert: Did you know that a dangerous disease is killing one person every 33 seconds?…
Top Global Health Stories of 2024: Breakthroughs, Challenges, and Innovations The year 2024 has been…